Phase II investigation of a PARP inhibitor (olaparib) in castration resistant prostate cancer (CRPC) which incorporates the possibility that treatment effect may be restricted to b...

by A’Hern Roger, DeBono Johann, Sandhu Shahneen, Kalaitzaki Eletheria, Usdin Martine, Hall Emma E
Published 2011-12-01

Females with paired occurrence of cancers in the UADT and genital region have a higher frequency of either Glutathione S-transferase <it>M1/T1 </it>null genotype

by Jhavar Sameer G, Sarin Rajiv, Chopra Supriya, Kotnis Ashwin, Mulherkar Rita, A'Hern Roger, Agarwal Jai, Shrivastava Shyam, Dinshaw Ketayun A
Published 2005-03-01